Drug search by name

Antihemophilic Factor/VWF Complex (Human) and Thromboembolic reactions

Result of checking the interaction of drug Antihemophilic Factor/VWF Complex (Human) and disease Thromboembolic reactions for safety when used together.

Check result:

Antihemophilic Factor/VWF Complex (Human) <> Thromboembolic reactions

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Thromboembolic reactions including disseminated intravascular coagulation (DIC), venous thrombosis, pulmonary embolism, myocardial infarction, and stroke can occur after therapy with von Willebrand factor, particularly in patients with risk factors for thrombosis. Monitor for early signs and symptoms of thrombosis such as pain, swelling, discoloration, dyspnea, cough, hemoptysis, and syncope and have prophylaxis measures against thromboembolism instituted according to current recommendations.

Antihemophilic Factor/VWF Complex (Human)

Generic Name: antihemophilic factor / von willebrand factor

Brand Name: Alphanate, Humate-P, Wilate, Wilstart, Dried Factor VIII Fraction Type 8Y, Haemate P, Optivate

Synonyms: Antihemophilic and von Willebrand factor complex, Antihemophilic Factor/von Willebrand Factor Complex (Human)

What is Antihemophilic Factor/VWF Complex (Human)?